Cases selected for the AskAnzal weekly PMCPA insight newsletter
A PCT adviser challenged AstraZenecaβs Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found…
PMCPA case AUTH/3006/12/17 (Director v Lilly) concerning clinical trial disclosure for Trulicity. Outcome: No breach; matter was outwith…
Complaint alleged Facebook/Twitter meeting adverts lacked sponsorship statements and reached the public. Panel initially found a Clause 22.4…
PMCPA case AUTH/2188/12/08: complaint about conduct of a representative. The matter was ruled outwith the scope of the…
Janssenβs BSR βPipelines in PsAβ innovation theatre session was ruled not to be legitimate scientific exchange and to…
Employee complaint upheld after Britannia used βApo-go Pumpβ name/logo despite Apo-go not being supplied as a pump. Panel…
Complaint alleged GSK promoted unlicensed RSV vaccine and Covid-19 antibody treatment to the public via LinkedIn. Panel ruled…
Anonymous nurse alleged a Sanofi account executive pressured them to sign up to a diabetes therapy review service…
A complaint alleged promotion of Nucala (mepolizumab) on LinkedIn. The PMCPA recorded the case as outwith the scope…
A LinkedIn sponsored message promoting Ogluo (glucagon) was received by a non-HCP. The Panel found public promotion plus…
One real case. One key lesson. Every week β free.